[Market Wired] SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN) (Trend Analysis) announced that Wilson W. Cheung, Chief Financial Officer, will present a corporate overview and business update at the Aegis Capital Corp.
FOSTER CITY, CA, Oct 30, 2014 (Marketwired via COMTEX) -- SciClone Pharmaceuticals, Inc. SCLN, -0.58% today announced that it plans to report financial results for the third quarter 2014 on Monday, November 10, 2014.
Revenues: Revenues in the third quarter of 2014 were $34.3 million, compared to $35.2 million for the same period in 2013. GAAP Basic EPS: GAAP basic earnings per share were $0.16 for both the third quarters of 2014 and 2013.
Investors eyeing a purchase of SciClone Pharmaceuticals, Inc. (Symbol: SCLN) shares, but tentative about paying the going market price of $8.30/share, might benefit from considering selling puts among the alternative strategies at their disposal.